Efficacy of Direct-acting Antivirals in Hemodialysis Patients with Chronic Hepatitis C: A Real-life Retrospective Study

AYDIN N. N., AKSOY F., Yavuz I., Iskender S., Yildirim A. A., YILDIZ İ. E., ...Daha Fazla

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, cilt.25, sa.3, ss.105-108, 2019 (ESCI) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 25 Sayı: 3
  • Basım Tarihi: 2019
  • Doi Numarası: 10.4274/vhd.galenos.2019.2019.0025
  • Dergi Adı: VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.105-108
  • Anahtar Kelimeler: Hepatitis C, hemodialysis, direct-acting antiviral agent, INFECTED PATIENTS, VIRUS-INFECTION, REGIMENS, KIDNEY, SAFETY, MANAGEMENT
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır

Özet

Objectives: Hepatitis C virus (HCV) infection is common among hemodialysis (HD) patients and is associated with increased morbidity and mortality. New generation direct-acting antiviral (DAA) agents are safe and effective in treatment HCV infection in HD patients. The aim of this a multi-center study was to assess the efficacy of DAAs in HD patients with HCV infection.